Investigating how dendritic cells affect the immune response in cancer

Metabolic checkpoint in dendritic cell subsets and adaptive immunity

NIH-funded research St. Jude Children's Research Hospital · NIH-11016907

This study is looking at how certain immune cells help the body fight cancer, with the hope of finding new ways to boost the immune response for patients battling the disease.

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital NIH-funded
Lab location1 site (Memphis, United States)
Project IDNIH-11016907 on NIH RePORTER

What this research studies

This research focuses on understanding the role of dendritic cell subsets in regulating the adaptive immune response, particularly in the context of cancer. By examining how these immune cells interact with cancer cells and influence anti-tumor immunity, the study aims to identify potential metabolic checkpoints that could be targeted for therapeutic benefit. Patients may benefit from insights gained into how their immune systems can be harnessed to fight cancer more effectively. The research employs advanced biochemical assays and algorithms to analyze immune responses and cancer progression.

Who could benefit from this research

Good fit: Ideal candidates for participation are cancer patients who are seeking innovative therapies to boost their immune response.

Not a fit: Patients with non-cancerous conditions or those who are not currently undergoing cancer treatment may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for enhancing the body's immune response against cancer.

How similar studies have performed: Previous research has shown promising results in enhancing anti-tumor immunity through similar approaches, indicating a potential for success in this area.

Where this research is happening

Memphis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions anti-cancer therapy
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.